Blood-pressure monitoring goes mobile
Apple sold 5 million iPhone 5 phones in the first weekend; thus, the new smartphone was available, so the newly compatible iHealth Wireless Blood Pressure Wrist Monitor has a lot of potential. Right now, it’s one of the hottest selling items in the blood-pressure monitor space with more than $137,000 in sales for the 12 weeks ended Aug. 12, up a whopping 45,882.2% across food, drug and mass (excluding Walmart), according to SymphonyIRI Group. The new wrist monitor adds motion sensor technology to increase accuracy. Users can track and share the results of their measurements using the free companion iHealth App for iOS devices.
The article above is part of the DSN Category Review Series. For the complete Diagnostics Sell-Through Report, including extensive charts, data and more analysis, click here.
ReportersNotebook — Over the Counter, 10/15/12
SUPPLIER NEWS — Summit Laboratories recently launched a pair of skin care items ideal for people with diabetes. Aside from kidney and eye disorders, skin disorders are one of the top challenges for diabetics. Summit Laboratories’ Dr. Fred Summit Type 1 & 2 Diabetic Rehydrating Cleanser and Cream provide a one-two punch to help promote proper leg and foot care. The pair of products are being merchandised as a solution for dry and itching skin associated with diabetes, and retail for $6.99 and $12.99, respectively.
The Senate last month passed a resolution naming October 2012 National Medicine Abuse Awareness Month. The Senate resolution urges communities to carry out programs and activities to educate parents and youth of the potential dangers associated with medicine abuse. “While over-the-counter and prescription medicines are safe and necessary when used properly, too many teens are abusing these drugs to get high,” stated Gen. Arthur Dean, chairman and CEO of the Community Anti-Drug Coalitions of America. Over the course of October, CADCA coalitions across the United States will be holding events to educate their communities about the dangers of medicine abuse and to discuss solutions to the problem. “These grassroots efforts can spur a nationwide dialogue about prescription and over-the-counter drug abuse in communities and among families across the country,” Dean said.
Medicare, telemedicine to affect testing supplies sales
There are two issues concerning the business of diabetes monitoring that are playing out right now, one a little more immediate.
As soon as 2013, when Medicare’s competitive bidding of durable medical equipment — which includes diabetes testing supplies — as it relates to mail order goes into effect, many pharmacies may be precluded from delivering diabetes test supplies to their patients. Currently 45% of community pharmacies deliver diabetes supplies to assisted living facilities, according to the National Community Pharmacists Association.
Sales of lancets and devices across food, drug and mass (excluding Walmart) totaled $17.2 million for the 52 weeks ended Aug. 12, up 3.1%, according to SymphonyIRI group data.
The second issue: losing the care opportunity of that diabetes patient as telemedicine opportunities develop. Nipro and NextGen Healthcare Information Systems recently partnered on a connectivity agreement that enables users of the NextGen Ambulatory EHR instant access to data points captured by patients at home who are using the Nipro TRUEresult blood-glucose monitoring system.
Right now it’s more push than pull, however, as caregivers only access the data during a consult as opposed to remote patient monitoring.
The article above is part of the DSN Category Review Series. For the complete Diabetes Buy-In Report, including extensive charts, data and more analysis, click here.